Secondary Headache Disorders: Approach, Workup, and Special Considerations for Select Populations

Friedman, Sarah A.; Masters-Israilov, Alina; Robbins, Matthew S.

doi:10.1055/s-0042-1757753

Cited by 4 publications

(3 citation statements)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The density of headaches (the number of days with headache per month) was different between the regions (p < 0.001). In pairwise comparisons, it was detected that the patients in Africa (5.93 ± 1.06 [0–30]) referred to the hospital with a lower density of headaches than those in Turkey (11.68 ± 0.53 [0–30]), the Middle East (15.97 ± 1.73 [2–30]), and Asia (11.19 ± 2.15 [0–30]) (p < 0.001) (Figure 4).…”

Section: Resultsmentioning

confidence: 99%

“…The severity and density of headaches play a crucial role in diagnosing and treating secondary headache disorders (17). A recent systematic review emphasized their significance and suggested thorough evaluations for patients with severe or persistent headaches (18). Our study observed significant differences in pain severity and density among regions, with patients from Africa reporting milder pain.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: A cross-sectional, multicenter study

Evlice,

Genç,

Uluduz

et al. 2023

Cephalalgia

View full text Add to dashboard Cite

Background This multicenter cross-sectional study aimed to determine the frequency and characteristics of secondary headaches in different geographic regions, including Turkey, the Middle East, Asia, and Africa. Methods Patients were admitted to the study on a particular day each week for five consecutive weeks between 1 April and 16 May 2022. Before the study, all researchers underwent a constructed briefing about the use and code of the ICHD-3 criteria. The study was conducted in two stages. In the first stage, data on secondary headaches were compared between the regions. In the second stage, the sub-diagnoses of secondary headaches were analyzed only in Turkey. Results A total of 4144 (30.0%) of the 13,794 patients reported headaches as the main symptoms at admission. A total of 422 patients were excluded from the study. In total, 1249 (33.4%) of 3722 patients were diagnosed as having secondary headaches (Turkey [n = 1039], Middle East [n = 80], Asia [n = 51], Africa [n = 79]). The frequency of secondary headaches (Turkey 33.6%, Africa 30.1%, Middle East 35.5%, Asia 35.4%) did not differ significantly between the regions (p > 0.05). The most common subtype of secondary headaches was headache attributed to substances or their withdrawal in all the studied regions. There was a female predominance in all regions, but it was lower in Africa than in Turkey. The severity and density of headaches differed significantly between the regions, with patients from Africa reporting milder pain than patients from other regions. In Turkey, the most common sub-diagnoses of secondary headaches were medication overuse headache, idiopathic intracranial hypertension, and cervicogenic headache. Conclusion In the present study, one in three patients with a headache had a secondary headache. Headache attributed to substances or their withdrawal was the most common subtype of secondary headaches in all the studied regions. The female predominance of secondary headaches was lower in Africa than in Turkey. The severity and density of headaches differed significantly between regions, with patients from Africa reporting milder pain.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: A cross-sectional, multicenter study

Evlice,

Genç,

Uluduz

et al. 2023

Cephalalgia

View full text Add to dashboard Cite

show abstract

“…It should be considered that some COVID-19 cases can be associated with cerebrovascular complications. Patients with these symptoms should be urgently sent for the appropriate neuro-imaging studies [15 ▪ ].…”

Section: Headache As a Symptom Of Acute Coronavirus Disease 2019mentioning

confidence: 99%

Long COVID and especially headache syndromes

Tana¹,

Giamberardino

Martelletti³

2023

Current Opinion in Neurology

View full text Add to dashboard Cite

Purpose of reviewThis is an expert overview on recent literature about the complex relationship between coronavirus disease 2019 (COVID-19) and headache. Recent findingsLong COVID is a clinical syndrome characterized by the presence of persistent symptoms following the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Headache is one of the most common symptoms and is described most often as throbbing pain, associated with photo and phonofobia and worsening with physical exercise. In acute COVID-19, headache is usually described as moderate or severe, diffuse and oppressive although sometimes it has been described with a migraine-like phenotype, especially in patients with a previous history of migraine. Headache intensity during acute phase seems to be the most important predictor of duration of headache over time. Some COVID-19 cases can be associated with cerebrovascular complications, and red flags of secondary headaches (e.g. new worsening or unresponsive headache, or new onset of neurological focal signs) should be urgently investigated with imaging. Treatment goals are the reduction of number and intensity of headache crises, and the prevention of chronic forms.

show abstract

Evaluación de la calidad y manejo de la cefalea en un paciente ingresado en el área de Neurociencia. Estudio CALMA

Gine-Cipres,

Torres Ferrus,

Gallardo

et al. 2024

Revista Científica de la Sociedad Española de Enfermería Neurol

View full text Add to dashboard Cite

Secondary Headache Disorders: Approach, Workup, and Special Considerations for Select Populations

Cited by 4 publications

References 74 publications

Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: A cross-sectional, multicenter study

Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: A cross-sectional, multicenter study

Long COVID and especially headache syndromes

Evaluación de la calidad y manejo de la cefalea en un paciente ingresado en el área de Neurociencia. Estudio CALMA

Contact Info

Product

Resources

About